Treat "Mochi Health vs Ro for GLP-1: Two Rising Telehealth Platforms" as a way to pressure-test a decision before money, medication, or provider access is involved
Third-party testing and COA verification Simple Peptide claims each batch undergoes independent third-party testing for purity and potency
After taking the daily pill for about 15 months, heres what participants experienced: Average weight loss of 13.6% across all participants, even those who werent perfectly consistent 16.6% average loss when the medication was taken consistently More than 3 out of 4 participants lost at least 5% of their body weight About 1 in 3 hit the 20% mark or higher But the benefits went beyond what the scale showed
Yes, our Shapely weight loss program in Brooklyn, New York is designed with flexibility and accessibility in mind, ensuring that you can access it from any device with internet connectivity
Before its development, GLP-1 receptor agonists like Semaglutide were the gold standard